ENDRA Life Sciences (NDRA) Competitors $4.24 -0.01 (-0.24%) Closing price 03/28/2025 03:50 PM EasternExtended Trading$4.22 -0.03 (-0.59%) As of 03/28/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock NDRA vs. NURO, WOK, PAVM, STRR, BSGM, MHUA, LUCY, POAI, OSRH, and BLACShould you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include NeuroMetrix (NURO), WORK Medical Technology Group LTD Ordinary Shares (WOK), PAVmed (PAVM), Star Equity (STRR), BioSig Technologies (BSGM), Meihua International Medical Technologies (MHUA), Innovative Eyewear (LUCY), Predictive Oncology (POAI), OSR (OSRH), and Bellevue Life Sciences Acquisition (BLAC). These companies are all part of the "medical equipment" industry. ENDRA Life Sciences vs. NeuroMetrix WORK Medical Technology Group LTD Ordinary Shares PAVmed Star Equity BioSig Technologies Meihua International Medical Technologies Innovative Eyewear Predictive Oncology OSR Bellevue Life Sciences Acquisition ENDRA Life Sciences (NASDAQ:NDRA) and NeuroMetrix (NASDAQ:NURO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, community ranking, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership. Do analysts rate NDRA or NURO? ENDRA Life Sciences currently has a consensus target price of $700,000.00, indicating a potential upside of 16,509,333.96%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe ENDRA Life Sciences is more favorable than NeuroMetrix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NeuroMetrix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in NDRA or NURO? 1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are owned by institutional investors. 0.0% of ENDRA Life Sciences shares are owned by company insiders. Comparatively, 7.3% of NeuroMetrix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher valuation & earnings, NDRA or NURO? NeuroMetrix has higher revenue and earnings than ENDRA Life Sciences. NeuroMetrix is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioENDRA Life SciencesN/AN/A-$10.06M-$901.150.00NeuroMetrix$3.77M2.41-$6.53M-$4.59-0.97 Which has more risk & volatility, NDRA or NURO? ENDRA Life Sciences has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 2.15, indicating that its stock price is 115% more volatile than the S&P 500. Does the media prefer NDRA or NURO? In the previous week, ENDRA Life Sciences and ENDRA Life Sciences both had 4 articles in the media. NeuroMetrix's average media sentiment score of 0.57 beat ENDRA Life Sciences' score of 0.22 indicating that NeuroMetrix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ENDRA Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroMetrix 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor NDRA or NURO? NeuroMetrix received 48 more outperform votes than ENDRA Life Sciences when rated by MarketBeat users. However, 62.77% of users gave ENDRA Life Sciences an outperform vote while only 56.91% of users gave NeuroMetrix an outperform vote. CompanyUnderperformOutperformENDRA Life SciencesOutperform Votes23662.77% Underperform Votes14037.23% NeuroMetrixOutperform Votes28456.91% Underperform Votes21543.09% Is NDRA or NURO more profitable? ENDRA Life Sciences has a net margin of 0.00% compared to NeuroMetrix's net margin of -203.71%. NeuroMetrix's return on equity of -42.56% beat ENDRA Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets ENDRA Life SciencesN/A -127.39% -103.77% NeuroMetrix -203.71%-42.56%-39.26% SummaryNeuroMetrix beats ENDRA Life Sciences on 10 of the 16 factors compared between the two stocks. Remove Ads Get ENDRA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NDRA vs. The Competition Export to ExcelMetricENDRA Life SciencesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.28M$3.28B$5.63B$7.84BDividend YieldN/A1.63%5.33%4.01%P/E Ratio0.0014.6123.5818.74Price / SalesN/A43.25388.2390.77Price / CashN/A44.0938.1734.64Price / Book0.003.406.894.23Net Income-$10.06M$94.03M$3.20B$247.47M7 Day Performance-1.40%-2.71%-3.06%-2.29%1 Month Performance-2.08%-12.00%1.51%-5.81%1 Year Performance-99.99%-20.19%9.37%-0.96% ENDRA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NDRAENDRA Life Sciences1.9803 of 5 stars$4.24-0.2%$700,000.00+16,509,334.0%-100.0%$2.28MN/A0.0020Upcoming EarningsShort Interest ↑Gap UpNURONeuroMetrix0.8722 of 5 stars$4.55+0.8%N/A+4.2%$9.33M$3.77M-0.9920Analyst ForecastShort Interest ↓News CoverageWOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.62-3.1%N/AN/A$9.05M$11.51M0.00226Gap DownPAVMPAVmed4.4495 of 5 stars$0.80-1.2%$19.00+2,275.0%-65.0%$8.86M$4.03M-0.1890Short Interest ↓News CoverageSTRRStar Equity1.1784 of 5 stars$2.67+10.3%N/A-43.2%$8.59M$50.38M-1.04460Analyst RevisionPositive NewsGap UpHigh Trading VolumeBSGMBioSig Technologies1.8134 of 5 stars$0.49-9.4%$2.75+456.9%-10.7%$8.51M$39,000.000.0050News CoverageHigh Trading VolumeMHUAMeihua International Medical Technologies2.0812 of 5 stars$0.34-1.0%N/A-53.9%$8.49M$94.25M0.00620Short Interest ↓LUCYInnovative Eyewear0.9048 of 5 stars$3.18-5.6%$20.00+528.9%-49.8%$7.77M$1.56M-0.339Earnings ReportGap DownPOAIPredictive Oncology2.2493 of 5 stars$1.12+0.9%$3.00+167.9%-43.1%$7.67M$1.48M-0.3730Short Interest ↓News CoverageOSRHOSRN/A$1.73+1.2%N/AN/A$6.99M$4.89B0.00N/ANews CoveragePositive NewsBLACBellevue Life Sciences AcquisitionN/A$1.71+7.5%N/A-77.5%$6.91MN/A0.00N/A Remove Ads Related Companies and Tools Related Companies NeuroMetrix Competitors WORK Medical Technology Group LTD Ordinary Shares Competitors PAVmed Competitors Star Equity Competitors BioSig Technologies Competitors Meihua International Medical Technologies Competitors Innovative Eyewear Competitors Predictive Oncology Competitors OSR Competitors Bellevue Life Sciences Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NDRA) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NDRA Stock Free NDRA Stock Alerts